658 studies found for:    Open Studies | "Bone Marrow Diseases"
Show Display Options
Rank Status Study
21 Recruiting Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia (CML) to Characterize the Efficacy and Safety of a Range of Doses
Condition: Myeloid Leukemia, Chronic, Chronic Phase
Interventions: Drug: ponatinib 45 mg;   Drug: ponatinib 30 mg;   Drug: ponatinib 15 mg
22 Recruiting Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Interventions: Drug: Sertraline;   Procedure: Bone Marrow Aspirate/Biopsy
23 Recruiting Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Condition: Polycythemia Vera
Intervention:
24 Recruiting AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
Condition: Polycythemia Vera
Intervention: Drug: Pegylated-Proline-interferon alpha-2b
25 Recruiting Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
Conditions: Primary Myelofibrosis;   Post-Polycythemia Vera Myelofibrosis;   Post-Essential Thrombocythemia Myelofibrosis
Intervention: Drug: NS-018
26 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   White Blood Cell Abnormalities;   Red Blood Cell Abnormalities
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product
27 Unknown  Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: Bortezomib
28 Recruiting Raltegravir for HAM/TSP
Condition: HTLV-I Infection
Intervention: Drug: Raltegravir
29 Not yet recruiting Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases
Conditions: Prostate Cancer;   Bone Metastases;   Prostate Neoplasms
Interventions: Drug: LHRH agonist/antagonist;   Drug: Bicalutamide;   Radiation: Radium-223 dichloride
30 Not yet recruiting Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Bone Metastasis
Interventions: Drug: Zoledronic acid;   Radiation: Radiotherapy
31 Recruiting Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
Condition: Bone Metastasis
Interventions: Drug: fentanyl transmucosal;   Drug: Placebo
32 Recruiting Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer
Conditions: Breast Cancer;   Prostate Cancer;   Bone Metastases
Intervention:
33 Recruiting Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS
Condition: Bone Metastases
Intervention: Radiation: Radiotherapy
34 Recruiting Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort
Condition: Bone Metastases
Intervention:
35 Recruiting Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
Conditions: Malignant Neoplasm;   Metastatic Malignant Neoplasm to the Bone
Interventions: Radiation: virtual non-calcium dual-energy computed tomography;   Radiation: computed tomography
36 Recruiting A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer;   Castration-resistant Prostate Cancer Metastatic to Bone
Interventions: Procedure: Blood Tests;   Procedure: CT scan and bone scan;   Procedure: FACBC PET/MRI in a subset of participants
37 Recruiting Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients
Conditions: Bone Metastasis;   Gastrointestinal Cancer
Intervention: Drug: Zoledronic acid
38 Recruiting A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms
Condition: Bone Metastases
Interventions: Radiation: Hypofractionated Radiation Treatment;   Radiation: One Radiation Treatment;   Behavioral: Questionnaire
39 Recruiting NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer
Conditions: Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M);   Untreated Bone Metastases
Interventions: Device: NaF PET/MRI;   Device: NaF PET/CT;   Device: FDG PET/CT
40 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years